Compare UBC Medical Indonesia Tbk. (LABS) vs Mitra Pinasthika Mustika Tbk. (MPMX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Mitra Pinasthika Mustika Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 651.75B), while Mitra Pinasthika Mustika Tbk. trades at Rp1,005 (market cap 4.41T). The key difference: Mitra Pinasthika Mustika Tbk. is far larger — about 6.8× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LABS | MPMX | |
|---|---|---|
Market Cap | 651.75B | 4.41T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Mitra Pinasthika Mustika Tbk.
PT Mitra Pinasthika Mustika Tbk (the Company) was establised by deed of notary public Mrs. Rukmasanti Hardjasatya, S.H., Jakarta No. 2 dated November 2, 1987 and amended with deed No.6 dated 1 July 1988.
Read more on MPMX →
